Distinct subcellular localization of tau and alpha-synuclein in lewy body disease

Abstract Lewy bodies and neurofibrillary tangles, composed of α-synuclein (α-syn) and tau, respectively, often are found together in the same brain and correlate with worsening cognition. Human postmortem studies show colocalization of α-syn and tau occurs in Lewy bodies, but with limited effort to...

Full description

Saved in:
Bibliographic Details
Main Authors: D. Luke Fischer, Marissa Menard, Omar Z. Abdelaziz, Nicholas M. Kanaan, Virginia G. Cobbs, Richard E. Kennedy, Geidy E. Serrano, Thomas G. Beach, Laura A. Volpicelli-Daley
Format: Article
Language:English
Published: BMC 2025-01-01
Series:Acta Neuropathologica Communications
Subjects:
Online Access:https://doi.org/10.1186/s40478-024-01913-w
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832585324140691456
author D. Luke Fischer
Marissa Menard
Omar Z. Abdelaziz
Nicholas M. Kanaan
Virginia G. Cobbs
Richard E. Kennedy
Geidy E. Serrano
Thomas G. Beach
Laura A. Volpicelli-Daley
author_facet D. Luke Fischer
Marissa Menard
Omar Z. Abdelaziz
Nicholas M. Kanaan
Virginia G. Cobbs
Richard E. Kennedy
Geidy E. Serrano
Thomas G. Beach
Laura A. Volpicelli-Daley
author_sort D. Luke Fischer
collection DOAJ
description Abstract Lewy bodies and neurofibrillary tangles, composed of α-synuclein (α-syn) and tau, respectively, often are found together in the same brain and correlate with worsening cognition. Human postmortem studies show colocalization of α-syn and tau occurs in Lewy bodies, but with limited effort to quantify colocalization. In this study, postmortem middle temporal gyrus tissue from decedents (n = 9) without temporal lobe disease (control) or with Lewy body disease (LBD) was immunofluorescently labeled with antibodies to phosphorylated α-syn (p-α-syn), tau phosphorylated at Ser202/Thr205 (p-tau), or exposure of tau’s phosphatase-activating domain (PAD-tau) as a marker of early tau aggregates. Immunofluorescence for major-histocompatibility complex class 2 (MHCII) and ionized calcium binding adaptor molecule 1 (Iba1) also was performed because inflammation is an additional pathological hallmark of LBDs, and they were a positive control for two markers known to colocalize. The abundance of p-α-syn, p-tau, and MHCII was significantly associated with diagnosis of LBD. Quantification of colocalization showed that MHCII and Iba1 colocalized, demonstrating activated immune cells are mostly microglia. However, p-α-syn rarely colocalized with p-tau or PAD-tau, although the overlap of p-α-syn with PAD-tau was significantly associated with LBD. In the rare cases pathologic α-syn and pathologic tau were found in the same Lewy body or Lewy neurite, tau appeared to surround α-syn but did not colocalize within the same structure. The relationship between tau and α-syn copathology is important for explaining clinical symptoms, severity, and progression, but there is no evidence for frequent, direct protein-protein interactions in the middle temporal gyrus.
format Article
id doaj-art-ebf4ff12a1204f5bb452069b9ead6560
institution Kabale University
issn 2051-5960
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series Acta Neuropathologica Communications
spelling doaj-art-ebf4ff12a1204f5bb452069b9ead65602025-01-26T12:57:21ZengBMCActa Neuropathologica Communications2051-59602025-01-0113111310.1186/s40478-024-01913-wDistinct subcellular localization of tau and alpha-synuclein in lewy body diseaseD. Luke Fischer0Marissa Menard1Omar Z. Abdelaziz2Nicholas M. Kanaan3Virginia G. Cobbs4Richard E. Kennedy5Geidy E. Serrano6Thomas G. Beach7Laura A. Volpicelli-Daley8Center for Neurodegeneration and Experimental Therapeutics, Department of Neurology, University of Alabama at BirminghamCenter for Neurodegeneration and Experimental Therapeutics, Department of Neurology, University of Alabama at BirminghamCenter for Neurodegeneration and Experimental Therapeutics, Department of Neurology, University of Alabama at BirminghamDepartment of Translational Neuroscience, College of Human Medicine, Michigan State UniversityCenter for Neurodegeneration and Experimental Therapeutics, Department of Neurology, University of Alabama at BirminghamDepartment of Medicine, University of Alabama at BirminghamBanner Sun Health Research InstituteBanner Sun Health Research InstituteCenter for Neurodegeneration and Experimental Therapeutics, Department of Neurology, University of Alabama at BirminghamAbstract Lewy bodies and neurofibrillary tangles, composed of α-synuclein (α-syn) and tau, respectively, often are found together in the same brain and correlate with worsening cognition. Human postmortem studies show colocalization of α-syn and tau occurs in Lewy bodies, but with limited effort to quantify colocalization. In this study, postmortem middle temporal gyrus tissue from decedents (n = 9) without temporal lobe disease (control) or with Lewy body disease (LBD) was immunofluorescently labeled with antibodies to phosphorylated α-syn (p-α-syn), tau phosphorylated at Ser202/Thr205 (p-tau), or exposure of tau’s phosphatase-activating domain (PAD-tau) as a marker of early tau aggregates. Immunofluorescence for major-histocompatibility complex class 2 (MHCII) and ionized calcium binding adaptor molecule 1 (Iba1) also was performed because inflammation is an additional pathological hallmark of LBDs, and they were a positive control for two markers known to colocalize. The abundance of p-α-syn, p-tau, and MHCII was significantly associated with diagnosis of LBD. Quantification of colocalization showed that MHCII and Iba1 colocalized, demonstrating activated immune cells are mostly microglia. However, p-α-syn rarely colocalized with p-tau or PAD-tau, although the overlap of p-α-syn with PAD-tau was significantly associated with LBD. In the rare cases pathologic α-syn and pathologic tau were found in the same Lewy body or Lewy neurite, tau appeared to surround α-syn but did not colocalize within the same structure. The relationship between tau and α-syn copathology is important for explaining clinical symptoms, severity, and progression, but there is no evidence for frequent, direct protein-protein interactions in the middle temporal gyrus.https://doi.org/10.1186/s40478-024-01913-wTauAlpha-synucleinLewy bodyNeurofibrillary tangleCopathology
spellingShingle D. Luke Fischer
Marissa Menard
Omar Z. Abdelaziz
Nicholas M. Kanaan
Virginia G. Cobbs
Richard E. Kennedy
Geidy E. Serrano
Thomas G. Beach
Laura A. Volpicelli-Daley
Distinct subcellular localization of tau and alpha-synuclein in lewy body disease
Acta Neuropathologica Communications
Tau
Alpha-synuclein
Lewy body
Neurofibrillary tangle
Copathology
title Distinct subcellular localization of tau and alpha-synuclein in lewy body disease
title_full Distinct subcellular localization of tau and alpha-synuclein in lewy body disease
title_fullStr Distinct subcellular localization of tau and alpha-synuclein in lewy body disease
title_full_unstemmed Distinct subcellular localization of tau and alpha-synuclein in lewy body disease
title_short Distinct subcellular localization of tau and alpha-synuclein in lewy body disease
title_sort distinct subcellular localization of tau and alpha synuclein in lewy body disease
topic Tau
Alpha-synuclein
Lewy body
Neurofibrillary tangle
Copathology
url https://doi.org/10.1186/s40478-024-01913-w
work_keys_str_mv AT dlukefischer distinctsubcellularlocalizationoftauandalphasynucleininlewybodydisease
AT marissamenard distinctsubcellularlocalizationoftauandalphasynucleininlewybodydisease
AT omarzabdelaziz distinctsubcellularlocalizationoftauandalphasynucleininlewybodydisease
AT nicholasmkanaan distinctsubcellularlocalizationoftauandalphasynucleininlewybodydisease
AT virginiagcobbs distinctsubcellularlocalizationoftauandalphasynucleininlewybodydisease
AT richardekennedy distinctsubcellularlocalizationoftauandalphasynucleininlewybodydisease
AT geidyeserrano distinctsubcellularlocalizationoftauandalphasynucleininlewybodydisease
AT thomasgbeach distinctsubcellularlocalizationoftauandalphasynucleininlewybodydisease
AT lauraavolpicellidaley distinctsubcellularlocalizationoftauandalphasynucleininlewybodydisease